Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
British Journal of Clinical Pharmacology|July 5, 2012
First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarialsJoerg J Moehrle, Stephan Duparc, Christoph Siethoff, et al.
The Journal of Infectious Diseases|October 27, 2015
Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax GenotypingHans-Peter Beck, Rahel Wampfler, Nick Carter, et al.
Malaria Research and Treatment|January 25, 2018
Sustained Effectiveness of a Fixed-Dose Combination of Artesunate and Amodiaquine in 480 Patients with Uncomplicated <i>Plasmodium falciparum</i> Malaria in Côte d'IvoireSerge Brice Assi, Abouo Franklin Nguessan, Yapo Thomas Aba, et al.
Malaria Journal|April 18, 2015
Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®)Alfred B Tiono, Halidou Tinto, Maroufou J Alao, et al.
Malaria Journal|May 13, 2024
Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malariaRaman Sharma, Hema Sharma, Siôn Jones, et al.
Malaria Journal|June 4, 2024
Defining the next generation of severe malaria treatment: a target product profileJane Achan, Aïssata Barry, Didier Leroy, et al.
Plos One|January 27, 2011
Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trialYi Poravuth, Duong Socheat, Ronnatrai Rueangweerayut, et al.
Malaria Journal|November 3, 2018
Injectable anti-malarials revisited: discovery and development of new agents to protect against malariaFiona Macintyre, Hanu Ramachandruni, Jeremy N Burrows, et al.
British Journal of Clinical Pharmacology|May 25, 2013
Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjectsAnn K Miller, Emma Harrell, Li Ye, et al.
BMJ Global Health|April 24, 2025
Prospective observational study to assess the feasibility and safety of appropriate <i>Plasmodium vivax</i> radical cure with tafenoquine or primaquine after quantitative G6PD testing during pilot implementation in ThailandPrayuth Sudathip, Nardlada Khantikul, Aungkana Saejeng, et al.
Pageof 10